We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-1.89%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$154M
AUM Growth
-$90.8M
Cap. Flow
-$89.2M
Cap. Flow %
-57.92%
Top 10 Hldgs %
20.11%
Holding
827
New
297
Increased
13
Reduced
39
Closed
409

Sector Composition

Rank Sector Weight
1 Financials 21.13%
2 Technology 16.45%
3 Healthcare 14.29%
4 Industrials 11.13%
5 Consumer Discretionary 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JQC icon
551
Nuveen Credit Strategies Income Fund
JQC
$705M
-143,571
Closed -$817K
KIM icon
552
Kimco Realty
KIM
$17.5B
-7,610
Closed -$178K
KIO
553
KKR Income Opportunities Fund
KIO
$450M
-63,436
Closed -$849K
KLAC icon
554
KLA
KLAC
$222B
-17,020
Closed -$1.07M
KNSA icon
555
Kiniksa Pharmaceuticals
KNSA
$6.31B
-17,361
Closed -$343K
KROS icon
556
Keros Therapeutics
KROS
$197M
-3,857
Closed -$61.1K
KRP icon
557
Kimbell Royalty Partners
KRP
$1.46B
-11,053
Closed -$179K
KRYS icon
558
Krystal Biotech
KRYS
$10.7B
-2,016
Closed -$316K
KT icon
559
KT
KT
$8.74B
-11,462
Closed -$178K
KURA icon
560
Kura Oncology
KURA
$793M
-7,336
Closed -$63.9K
KYMR icon
561
Kymera Therapeutics
KYMR
$8.66B
-1,686
Closed -$67.8K
LEGN icon
562
Legend Biotech
LEGN
$3.65B
-9,852
Closed -$321K
LEN icon
563
Lennar Class A
LEN
$20.4B
-6,832
Closed -$902K
LGND icon
564
Ligand Pharmaceuticals
LGND
$5.77B
-3,080
Closed -$330K
LLY icon
565
Eli Lilly
LLY
$1.08T
-1,287
Closed -$994K
LQDA icon
566
Liquidia Corp
LQDA
$7.72B
-6,457
Closed -$75.9K
LRMR icon
567
Larimar Therapeutics
LRMR
$377M
-11,635
Closed -$45K
LXRX icon
568
Lexicon Pharmaceuticals
LXRX
$1.03B
-425,269
Closed -$314K
MA icon
569
Mastercard
MA
$498B
-2,268
Closed -$1.19M
MAA icon
570
Mid-America Apartment Communities
MAA
$16B
-1,089
Closed -$168K
MAIN icon
571
Main Street Capital
MAIN
$5.05B
-9,910
Closed -$581K
MDGL icon
572
Madrigal Pharmaceuticals
MDGL
$12.6B
-1,156
Closed -$357K
MELI icon
573
Mercado Libre
MELI
$94.5B
-556
Closed -$945K
MFIC icon
574
MidCap Financial Investment
MFIC
$801M
-62,311
Closed -$841K
MIRM icon
575
Mirum Pharmaceuticals
MIRM
$6.56B
-8,270
Closed -$342K

Similar funds

Virtus ETF Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Virtus ETF Advisers held 827 positions worth $154M, down 37% from $245M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Virtus ETF Advisers withdrew a net $89.2M in Q1 2025, closing 409 positions and reducing 39 holdings. Its most notable exit was OFS Credit Co, an estimated $2.26M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Virtus ETF Advisers opened a new position in ICICI Bank worth $8.23M.

  • Virtus ETF Advisers's largest Q1 2025 buy was ICICI Bank: 261,046 shares worth $8.23M.
  • Virtus ETF Advisers added most to Microsoft in Q1 2025, an estimated $1.1M increase.
  • Virtus ETF Advisers's biggest Q1 2025 reduction was Fortinet, cutting an estimated $1.33M.
  • Virtus ETF Advisers fully exited OFS Credit Co in Q1 2025, selling an estimated $2.26M.
  • Virtus ETF Advisers's ten largest holdings make up 20% of its $154M portfolio in Q1 2025.
  • Virtus ETF Advisers opened 297 new positions and closed 409 in Q1 2025.
  • Virtus ETF Advisers's portfolio value fell 37% quarter-over-quarter to $154M.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.